STOCK TITAN

bioAffinity Technologies: HRT Financial tops 10% ownership

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(High)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
3

Rhea-AI Filing Summary

bioAffinity Technologies, Inc. (BIAF) reported that HRT Financial LP became a beneficial owner of more than 10% of outstanding common stock on September 22, 2026. Immediately following the transaction that resulted in that status, HRT Financial LP directly held 116,782 common shares. Its reported holdings also included 1,183 warrants, each exercisable for 1/450 of a common share, with an exercise price of $3,645 per whole share and an expiration date of June 22, 2027.

Insider HRT FINANCIAL LP
Role 10% Owner
Type Security Shares Price Value
Holding Warrant (rights to buy) F2 -- -- --
Holding Common Stock F1 -- -- --
Holdings: Warrant (rights to buy) — 2.6289 warrants (Direct); Common Stock — 116,782 shares (Direct)
Footnotes (2)
  1. F1. The reporting person became the beneficial owner of more than 10% of the outstanding Common Stock on September 22, 2026. The amount reported represents shares of Common Stock directly held by the reporting person immediately following the transaction that resulted in such status.
  2. F2. Represents 1,183 warrants held at the time described in footnote (1). Each warrant is exercisable for 1/450 of a share of Common Stock; the exercise price shown is per whole share, as adjusted for the issuer's reverse stock splits. The underlying amount is rounded to four decimal places.
Beneficial ownership threshold More than 10% HRT Financial LP became a beneficial owner on September 22, 2026
Directly held common stock 116,782 shares Immediately following the transaction that resulted in beneficial-owner status
Warrants 1,183 warrants Held at the time described in the ownership footnote
Underlying common stock 2.6289 shares Underlying amount reported for the warrants, rounded to four decimal places
Warrant exercise ratio 1/450 of a share per warrant Each warrant is exercisable for this portion of a common share
Warrant exercise price $3,645 per whole share Adjusted for the issuer's reverse stock splits
Warrant expiration June 22, 2027 Expiration date reported for the warrants
beneficial owner regulatory
"became the beneficial owner of more than 10%"
A beneficial owner is the person who ultimately owns or controls a financial asset or property, even if their name isn't directly on official documents. Think of it like someone who secretly holds the keys to a safe deposit box—others may appear to have access, but the true owner is the one who benefits from what's inside. Identifying beneficial owners helps ensure transparency and prevent illegal activities like money laundering or fraud.
warrants financial
"1,183 warrants held"
Warrants are special documents that give you the right to buy a company's stock at a set price before a certain date. They are often used as a way for companies to attract investors or raise money, and their value can increase if the company's stock price goes up.
exercise price financial
"the exercise price shown is per whole share"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
reverse stock splits technical
"as adjusted for the issuer's reverse stock splits"
A reverse stock split is when a company combines multiple existing shares into fewer higher-priced shares—like trading four small slices of a pie for one larger slice. It doesn’t change the overall value of an investor’s holdings immediately, but it raises the per-share price and can matter to investors because it can affect market perception, stock exchange listing eligibility, and trading liquidity, and it changes share counts used in investor metrics.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many BIAF shares did HRT Financial LP hold after becoming a 10% owner?

HRT Financial LP directly held 116,782 common shares immediately following the transaction that resulted in its status as a beneficial owner of more than 10% of bioAffinity Technologies' outstanding common stock on September 22, 2026.

What warrant terms did HRT Financial LP report for BIAF?

HRT Financial LP reported 1,183 warrants, each exercisable for 1/450 of a common share. The exercise price was $3,645 per whole share, as adjusted for the issuer's reverse stock splits, and the warrants expire June 22, 2027.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 3
FORM 3UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0104
Estimated average burden
hours per response:0.5
1. Name and Address of Reporting Person*
HRT FINANCIAL LP

(Last)(First)(Middle)
3 WORLD TRADE CENTER, 175 GREENWICH STRE
76TH FLOOR

(Street)
NEW YORK NEW YORK 10007

(City)(State)(Zip)

UNITED STATES

(Country)
2. Date of Event Requiring Statement (Month/Day/Year)
09/22/2026
3. Issuer Name and Ticker or Trading Symbol
bioAffinity Technologies, Inc. [ BIAF ]
3a. Foreign Trading Symbol
5. If Amendment, Date of Original Filed (Month/Day/Year)
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
DirectorX10% Owner
Officer (give title below)Other (specify below)
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock116,782(1)D
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year)3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date ExercisableExpiration DateTitleAmount or Number of Shares
Warrant (rights to buy)06/22/202206/22/2027Common Stock2.6289(2)$3,645D
Explanation of Responses:
1. The reporting person became the beneficial owner of more than 10% of the outstanding Common Stock on September 22, 2026. The amount reported represents shares of Common Stock directly held by the reporting person immediately following the transaction that resulted in such status.
2. Represents 1,183 warrants held at the time described in footnote (1). Each warrant is exercisable for 1/450 of a share of Common Stock; the exercise price shown is per whole share, as adjusted for the issuer's reverse stock splits. The underlying amount is rounded to four decimal places.
Adam Nunes11/19/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

Keep reading